Due to its ubiquitous nature and presence in all cells, PEA has wide-ranging therapeutic applications
PMID: 16032049
While results may vary, many users report noticeable improvements in appetite control, energy levels, and overall well-being within a few weeks, with optimal results often seen in 23 months
The team suggests their findings point to repurposing anti-diabetic weight loss-inducing drugs including semaglutide, dulaglutide, and liraglutide (glucagon-like peptide-1 receptor agonists), empagliflozin (a sodium-glucose cotransporter-2 inhibitor), and metformin (a biguanide), for MS
Identity Transitions : Mental health professionals are developing specialized approaches for helping patients navigate the psychological aspects of rapid physical transformation, including changes in how others perceive and interact with them
Davies, Karen Brown, Dimitris Papamargaritis Diabetes, Obesity and Metabolism.2025